Molecular basis of Pirh2-mediated p53 ubiquitylation

被引:87
|
作者
Sheng, Yi [1 ,2 ,4 ]
Laister, Rob C. [1 ,2 ]
Lemak, Alexander [1 ,2 ]
Wu, Bin [1 ,2 ]
Tai, Elizabeth [1 ,2 ]
Duan, Shili [1 ,2 ]
Lukin, Jonathan [1 ,2 ]
Sunnerhagen, Maria [3 ]
Srisailam, Sampath [1 ,2 ]
Karra, Murthy [1 ,2 ]
Benchimol, Sam [4 ]
Arrowsmith, Cheryl H. [1 ,2 ]
机构
[1] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada
[2] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada
[3] Linkoping Univ, IFM, S-58183 Linkoping, Sweden
[4] York Univ, Dept Biol, N York, ON M3J 1P3, Canada
基金
美国国家卫生研究院;
关键词
D O I
10.1038/nsmb.1521
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Pirh2 (p53-induced RING-H2 domain protein; also known as Rchy1) is an E3 ubiquitin ligase involved in a negative-feedback loop with p53. Using NMR spectroscopy, we show that Pirh2 is a unique cysteine-rich protein comprising three modular domains. The protein binds nine zinc ions using a variety of zinc coordination schemes, including a RING domain and a left-handed beta-spiral in which three zinc ions align three consecutive small beta-sheets in an interleaved fashion. We show that Pirh2-p53 interaction is dependent on the C-terminal zinc binding module of Pirh2, which binds to the tetramerization domain of p53. As a result, Pirh2 preferentially ubiquitylates the tetrameric form of p53 in vitro and in vivo, suggesting that Pirh2 regulates protein turnover of the transcriptionally active form of p53.
引用
收藏
页码:1334 / 1342
页数:9
相关论文
共 50 条
  • [31] Lessons from interconnected ubiquitylation and acetylation of p53: think metastable networks
    Benkirane, Monsef
    Sardet, Claude
    Coux, Olivier
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2010, 38 : 98 - 103
  • [32] Tetramerization-defects of p53 result in aberrant ubiquitylation and transcriptional activity
    Lang, Valerie
    Pallara, Chiara
    Zabala, Amaia
    Lobato-Gil, Sofia
    Lopitz-Otsoa, Fernando
    Farras, Rosa
    Hjerpe, Roland
    Torres-Ramos, Monica
    Zabaleta, Lorea
    Blattner, Christine
    Hay, Ronald T.
    Barrio, Rosa
    Carracedo, Arkaitz
    Fernandez-Recio, Juan
    Rodriguez, Manuel S.
    Aillet, Fabienne
    MOLECULAR ONCOLOGY, 2014, 8 (05) : 1026 - 1042
  • [33] Interplay between MDM2, MDMX, Pirh2 and COP1: the negative regulators of p53
    Wang, Lan
    He, Guifen
    Zhang, Pingzhao
    Wang, Xiang
    Jiang, Mei
    Yu, Long
    MOLECULAR BIOLOGY REPORTS, 2011, 38 (01) : 229 - 236
  • [34] MDM2 and BCL-2: to p53 or not to p53?
    Wang, Eunice S.
    BLOOD, 2023, 141 (11) : 1237 - 1238
  • [35] P53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
    Yin, YL
    Luciani, MG
    Fåhraeus, R
    NATURE CELL BIOLOGY, 2002, 4 (06) : 462 - 467
  • [36] p53 stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products
    Yili Yin
    Charles W. Stephen
    M. Gloria Luciani
    Robin Fåhraeus
    Nature Cell Biology, 2002, 4 : 462 - 467
  • [37] Pirh2与p53在甲状腺癌中的研究进展
    熊芳
    范培芝
    张超杰
    大连医科大学学报, 2015, 37 (02) : 196 - 198
  • [38] Phosphorylation of Pirh2 by Calmodulin-dependent kinase II impairs its ability to ubiquitinate p53
    Duan, Shanshan
    Yao, Zhan
    Hou, Dezhi
    Wu, Zhengsheng
    Zhu, Wei-Guo
    Wu, Mian
    EMBO JOURNAL, 2007, 26 (13): : 3062 - 3074
  • [39] Molecular mechanisms of functional rescue mediated by P53 tumor suppressor mutations
    Tan, Yu-Hong
    Chen, Y. Morris
    Ye, Xiang
    Lu, Qiang
    Tretyachenko-Ladokhina, Vira
    Yang, Wei
    Senear, Donald F.
    Luo, Ray
    BIOPHYSICAL CHEMISTRY, 2009, 145 (01) : 37 - 44
  • [40] Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL
    Wiederschain, D
    Kawai, H
    Gu, JJ
    Shilatifard, A
    Yuan, ZM
    MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (12) : 4230 - 4246